|
Overactive Bladder
|
0.590 |
Biomarker
|
disease |
BEFREE |
Nerve growth factor was associated with overactive bladder symptoms in patients with benign prostatic hyperplasia as well as with the assessment of successful long-term treatment outcome of bladder outlet obstruction with symptoms of overactive bladder.
|
29630981 |
2018 |
|
Overactive Bladder
|
0.590 |
Biomarker
|
disease |
BEFREE |
The objectives of this study include (1) to evaluate the effectiveness and safety of acupuncture treatment in patients with OAB on reduction in the frequency of incontinence episodes as derived from a 7-day voiding diary, (2) to evaluate whether acupuncture treatment could improve subjective symptoms in patients with OAB and (3) to examine the feasibility of using NGF as a biomarker for overactive bladder and test correlation with the effectiveness of acupuncture intervention.
|
30005707 |
2018 |
|
Overactive Bladder
|
0.590 |
Biomarker
|
disease |
BEFREE |
Association between Metabolic Syndrome and Serum Nerve Growth Factor Levels in Women with Overactive Bladder.
|
28637031 |
2018 |
|
Overactive Bladder
|
0.590 |
Biomarker
|
disease |
BEFREE |
At baseline, urinary levels of NGF and BDNF were similar between SUI and healthy women (NGF: 2.10 ± 0.68 vs 1.99 ± 1.05; BDNF: 1.99 ± 0.71 vs 1.81 ± 0.90), and significantly inferior to OAB wet patients (NGF: 2.10 ± 0.68 vs 2.50 ± 0.54, P < .05; BDNF: 1.99 ± 0.71 vs 2.71 ± 0.45, P < .05).
|
27697460 |
2017 |
|
Overactive Bladder
|
0.590 |
AlteredExpression
|
disease |
BEFREE |
The aim of this study was to compare the expression of urinary nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), substance P (SP), and calcitonin-gene related peptide (CGRP) in women with and without overactive bladder (OAB).
|
27062604 |
2017 |
|
Overactive Bladder
|
0.590 |
Biomarker
|
disease |
BEFREE |
Urinary Nerve Growth Factor Can Predict Therapeutic Efficacy in Children With Overactive Bladder.
|
28161379 |
2017 |
|
Overactive Bladder
|
0.590 |
AlteredExpression
|
disease |
BEFREE |
After treatment, the level of NGF/Cr decreased significantly in OAB group.
|
28102552 |
2017 |
|
Overactive Bladder
|
0.590 |
Biomarker
|
disease |
BEFREE |
Re: Sheng W, Zhang H, Kirschner-Hermanns R. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis. Neurourol Urodyn. 2017;9999:1-8. doi: 10.1002/nau.23210.
|
28346713 |
2017 |
|
Overactive Bladder
|
0.590 |
Biomarker
|
disease |
BEFREE |
Urinary concentration of brain-derived neurotrophic factor and nerve growth factor will also be collected since it has been shown that patients with an overactive bladder have higher concentrations of these neuropeptides.
|
28159850 |
2017 |
|
Overactive Bladder
|
0.590 |
Therapeutic
|
disease |
RGD |
Nicorandil ameliorates hypertension-related bladder dysfunction in the rat.
|
22473863 |
2012 |
|
Overactive Bladder
|
0.590 |
Therapeutic
|
disease |
RGD |
Effect of hyaluronic acid on urine nerve growth factor in cyclophosphamide-induced cystitis.
|
21605172 |
2011 |
|
Overactive Bladder
|
0.590 |
Biomarker
|
disease |
CTD_human |
Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder.
|
16600756 |
2006 |